Enguerran Ripert

Principal

United Kingdom

Enguerran advises industrial clients, funds, and portfolio companies on strategy, acquisitions and organization design

Education

University College London
BSc(Hons) Chemistry

Past Experience

Frost & Sullivan
Senior consultant, Growth consulting practice
Voltalia
Consultant

Enguerran Ripert is a Principal at Arthur D. Little’s London office with 14 years of consulting experience across both the Energy & Utilities practice as well as the Technology & Innovation Management practices. 

He focuses on strategy, M&A transaction support, commercial due diligence, business analysis, market entry strategy, market assessment, and organizational design in technology-driven sectors. In the last decade, Enguerran has supported Fortune 1000 companies, Private Equity funds and portfolio companies across the UK, Europe, the Middle East and Asia. 

Enguerran is also a non-executive director to selected small and medium-sized enterprises during periods of change, currently including a portfolio company and a family office. He earned a bachelor of science degree in chemistry, with honors, from University College London. 

Innovation management
Many organizations have created significant business benefit by decentralizing R&D and innovation functions, thus improving the contribution of innovation to business unit performance. However, this often creates a conflict of ownership, as the alignment of R&D activities with corporate strategy then needs to be dealt with at group level. Frequently, the responsibility for alignment between corporate strategy and business unit innovation and R&D lands with the CTO, who needs the right processes and tools to achieve this.
Making sense of the bioeconomy
Fuels and chemicals produced from bio-based feedstocks, such aswaste wood and agricultural co-products, offer incredible potential.
Where now for oil?
The recent precipitous fall in oil was predicted by almost no-one. In this viewpoint we attempt to explain the economics of the change and highlight an emerging “new normal” for oil prices in which a medium term recovery occurs, but prices stay below US$80 per barrel. We also highlight the implications of this new normal.

Enguerran Ripert is a Principal at Arthur D. Little’s London office with 14 years of consulting experience across both the Energy & Utilities practice as well as the Technology & Innovation Management practices. 

He focuses on strategy, M&A transaction support, commercial due diligence, business analysis, market entry strategy, market assessment, and organizational design in technology-driven sectors. In the last decade, Enguerran has supported Fortune 1000 companies, Private Equity funds and portfolio companies across the UK, Europe, the Middle East and Asia. 

Enguerran is also a non-executive director to selected small and medium-sized enterprises during periods of change, currently including a portfolio company and a family office. He earned a bachelor of science degree in chemistry, with honors, from University College London. 

Innovation management
Many organizations have created significant business benefit by decentralizing R&D and innovation functions, thus improving the contribution of innovation to business unit performance. However, this often creates a conflict of ownership, as the alignment of R&D activities with corporate strategy then needs to be dealt with at group level. Frequently, the responsibility for alignment between corporate strategy and business unit innovation and R&D lands with the CTO, who needs the right processes and tools to achieve this.
Making sense of the bioeconomy
Fuels and chemicals produced from bio-based feedstocks, such aswaste wood and agricultural co-products, offer incredible potential.
Where now for oil?
The recent precipitous fall in oil was predicted by almost no-one. In this viewpoint we attempt to explain the economics of the change and highlight an emerging “new normal” for oil prices in which a medium term recovery occurs, but prices stay below US$80 per barrel. We also highlight the implications of this new normal.

More About Enguerran
  • University College London
    BSc(Hons) Chemistry
  • Frost & Sullivan
    Senior consultant, Growth consulting practice
  • Voltalia
    Consultant